Literature DB >> 28531286

Is foetal hyperexposure to androgens a cause of PCOS?

Panagiota Filippou1, Roy Homburg.   

Abstract

BACKGROUND: Polycystic ovary syndrome (PCOS) is the most common endocrinopathy affecting reproductive-aged women. The pathophysiology of this syndrome is still not completely understood but recent evidence suggests that the intra-uterine environment may be a key factor in the pathogenesis of PCOS, in particular, hyperexposure of the foetus to androgens. High concentrations of maternal serum testosterone during pregnancy have been shown to influence behaviour during childhood, the prevalence of autism disorders and anti-Mullerian hormone (AMH) concentrations in adolescence. They are also thought to re-programme the female reproductive axis to induce the features of PCOS in later life: oligo/anovulation, polycystic ovaries, hyperandrogenism and insulin resistance (IR). Support for this developmental theory for the aetiology of PCOS is gathering momentum, following results from first animal studies and now human data, which lend credence to many aspects of this hypothesis. OBJECTIVE AND RATIONALE: In this review the recent available evidence is presented to support the hypothesis that hyperandrogenic changes in the intra-uterine environment could play a major part in the aetiological basis of PCOS. SEARCH
METHODS: An extensive PubMED and MEDline database search was conducted. Relevant studies were identified using a combination of search terms: 'polycystic ovary syndrome', 'PCOS', 'aetiology', 'anti-Mullerian hormone', 'AMH', 'pathogenesis', 'kisspeptin', 'hyperandrogenism', 'insulin resistance', 'metabolic factors', 'placenta', 'developmental hypothesis', 'genetic and epigenetic origins'. OUTCOMES: A total of 82 studies were finally included in this review. There is robust evidence that a hyperandrogenic intra-uterine environment 'programmes' the genes concerned with ovarian steroidogenesis, insulin metabolism, gonadotrophin secretion and ovarian follicle development resulting in the development of PCOS in adult life. WIDER IMPLICATIONS: Once the evidence supporting this hypothesis has been expanded by additional studies, the door would be open to find innovative treatments and preventative measures for this very prevalent condition. Such measures could considerably ease the human and economic burden that PCOS creates.
© The Author 2017. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oup.com

Entities:  

Keywords:  PCOS; aetiology; androgens; anti-Mullerian hormone; developmental theory; epigenetics; insulin resistance; intra-uterine environment; kisspeptin; placenta

Mesh:

Substances:

Year:  2017        PMID: 28531286     DOI: 10.1093/humupd/dmx013

Source DB:  PubMed          Journal:  Hum Reprod Update        ISSN: 1355-4786            Impact factor:   15.610


  35 in total

1.  Female Offspring From Chronic Hyperandrogenemic Dams Exhibit Delayed Puberty and Impaired Ovarian Reserve.

Authors:  Zhiqiang Wang; Mingjie Shen; Ping Xue; Sara A DiVall; James Segars; Sheng Wu
Journal:  Endocrinology       Date:  2018-02-01       Impact factor: 4.736

2.  First ovarian response to gonadotrophin stimulation in rats exposed to neonatal androgen excess.

Authors:  Rebeca Chávez-Genaro; Gabriel Anesetti
Journal:  J Mol Histol       Date:  2018-10-09       Impact factor: 2.611

3.  Could perturbed fetal development of the ovary contribute to the development of polycystic ovary syndrome in later life?

Authors:  Monica D Hartanti; Roseanne Rosario; Katja Hummitzsch; Nicole A Bastian; Nicholas Hatzirodos; Wendy M Bonner; Rosemary A Bayne; Helen F Irving-Rodgers; Richard A Anderson; Raymond J Rodgers
Journal:  PLoS One       Date:  2020-02-20       Impact factor: 3.240

4.  Oocyte retrieval outcomes among adolescent transgender males.

Authors:  Hadar Amir; Asaf Oren; Emilie Klochendler Frishman; Onit Sapir; Yoel Shufaro; Anat Segev Becker; Foad Azem; Avi Ben-Haroush
Journal:  J Assist Reprod Genet       Date:  2020-05-20       Impact factor: 3.412

5.  Prenatal programming by testosterone of follicular theca cell functions in ovary.

Authors:  Danielle Monniaux; Carine Genêt; Virginie Maillard; Peggy Jarrier; Hans Adriaensen; Christelle Hennequet-Antier; Anne-Lyse Lainé; Corinne Laclie; Pascal Papillier; Florence Plisson-Petit; Anthony Estienne; Juliette Cognié; Nathalie di Clemente; Rozenn Dalbies-Tran; Stéphane Fabre
Journal:  Cell Mol Life Sci       Date:  2019-07-20       Impact factor: 9.261

Review 6.  A Narrative Review of Placental Contribution to Adverse Pregnancy Outcomes in Women With Polycystic Ovary Syndrome.

Authors:  Angela S Kelley; Yolanda R Smith; Vasantha Padmanabhan
Journal:  J Clin Endocrinol Metab       Date:  2019-11-01       Impact factor: 5.958

Review 7.  Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment.

Authors:  Héctor F Escobar-Morreale
Journal:  Nat Rev Endocrinol       Date:  2018-03-23       Impact factor: 43.330

Review 8.  In utero Androgen Excess: A Developmental Commonality Preceding Polycystic Ovary Syndrome?

Authors:  David H Abbott; Marissa Kraynak; Daniel A Dumesic; Jon E Levine
Journal:  Front Horm Res       Date:  2019-09-09       Impact factor: 2.606

9.  A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome.

Authors:  Ping Xue; Zhiqiang Wang; Xiaomin Fu; Junjiang Wang; Gopika Punchhi; Andrew Wolfe; Sheng Wu
Journal:  J Vis Exp       Date:  2018-10-02       Impact factor: 1.355

Review 10.  Curtailing PCOS.

Authors:  Selma Feldman Witchel; Helena J Teede; Alexia S Peña
Journal:  Pediatr Res       Date:  2019-10-18       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.